MacroGenics Inc. Stock
MacroGenics Inc. Stock
MacroGenics Inc. dominated the market today, gaining €0.60 (4.580%).
With 9 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 20 € there is a positive potential of 44.93% for MacroGenics Inc. compared to the current price of 13.8 €.
Our community identified positive and negative aspects for MacroGenics Inc. stock for the coming years. 5 users see the criterium "Worthwhile Investment for the next years" as a plus for the MacroGenics Inc. stock. On the other hand our users think that "Valuation (undervalued/overvalued)" could be a problem in the future.
Pros and Cons of MacroGenics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MacroGenics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
MacroGenics Inc. | 4.580% | -2.817% | -13.208% | 120.800% | 53.333% | -51.064% | - |
Salarius Pharmaceuticals Inc. | 2.420% | -18.824% | -22.617% | -76.389% | -25.405% | -98.665% | -99.992% |
Ardelyx Inc. | -1.160% | -6.371% | -22.654% | 73.980% | 16.955% | 25.791% | - |
Evolus Inc | -0.770% | 2.362% | -2.985% | 66.667% | 39.037% | 31.287% | - |
Comments
MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at Barclays PLC from $12.00 to $23.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MGNX provided by MarketBeat
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock, up previously from $7.00.
Show more
Ratings data for MGNX provided by MarketBeat
MacroGenics, Inc. (NASDAQ: MGNX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $17.00 price target on the stock.
Show more
Ratings data for MGNX provided by MarketBeat